Surgical Innovations Group PLC
10 May 2001
Surgical Innovations Group plc
Surgical Innovations Group plc ('the Company') has made an application for
9,280 new ordinary shares of 1p each to be admitted to trading on the
Alternative Investment Market.
The new shares have been allotted to a holder of the Company's convertible
loan notes who has given notice to convert the loan notes into ordinary
shares. The loan notes are being converted at the rate of 26.6667 ordinary
shares in the Company for every £1 nominal of convertible loan notes. This
equates to a price per ordinary share of 3.75p per share. The new ordinary
shares will rank pari passu with the existing ordinary shares
It is expected that the new shares will be admitted to trading on 18 May 2001.
END
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.